DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20195176

Relationship of cutaneous manifestations with inflammatory markers in diabetic nephropathic patients on heamodialysis

Srinivas Subbaramaiah, Nagendra Subbaramaiah, Anvitha Chidanand, Prashanthkumar Goudappala, Kashinath Rattihalli Thirumala Rao

Abstract


Background: Diabetic nephropathy is a serious life threatening complication of type-2 diabetes mellitus. Apart from severe kidney dysfunction these patients are prone to various cutaneous complications including psoriasis and eczema due to accumulated nitrogenous waste products. Inflammation is the basic cause of cutaneous complications and many inflammatory markers have been shown elevated in chronic kidney dysfunction. Hence a study has been planned to assess the levels of inflammatory markers such has C-reactive protein (CRP) and interlukin-6 (IL-6) as well as to correlate these markers with creatinine levels along with existing cutaneus complications.

Methods: The study included 50 diabetic nephropathic patients undergoing regular heamodialysis. A heparanised blood sample was collected and plasma was employed for estimation of glucose, creatinine, CRP and IL-6. A detailed dermatological examination was done to record the cutaneous complications like pruritis, xerosis, hyper pigmentation and half & half nails.

Results: The results show a significant raise in CRP and IL-6 levels in proportion to the severity of kidney dysfunction as reflected by creatinine levels. Also a positive relationship was observed between the inflammatory markers and multiplicity of cutaneous complications.

Conclusions: It can be concluded from the present study that evaluation of inflammatory markers, CRP and IL-6 along with creatinine is beneficial in controlling cutanious complications in DN patients undergoing regular heamodialysis.


Keywords


Diabetic nephropathy, Creatinine, C-reactive protein, Interlukin-6

Full Text:

PDF

References


Dowlatshahi E, Voort E, Arends L, Nijsten T. Markers of systemic inflammation in psoriasis:a systematic review and meta-analysis. Br J Dermatol. 2013;169:266-82.

Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in US adult population studies. J Allergy Clin Immunol. 2015;135:721-8.

Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;79:361-72.

Wan X, Zhang L, Gu H, Wang S, Liu X. The Association of Serum hsCRP and Urinary Alpha1-Microglobulin in Patients with Type 2 Diabetes Mellitus. BioMed Research International. 2019; 1-10.

Aliston CA. Non protein nitrogenous compounds and renal function. Clinical Chemistry, Concepts and Applications, Anderson SC, Cockayne S. Philadelphia, USA: Saunders Eds. 1993: 369.

Jodeph A. ASO-turbilatex. Euro E Pharma Ther. 1980;11:6061-717.

Tietz NW. Clinical Chemistry, 3rd Edition, WB Saunders & Co; 1987: 427-429.

Vasiliades J. Reaction of alkaline sodium picrate with creatinine:I. Kinetics and mechanism of formation of the mono-creatinine picric acid complex. Clin Chem. 1976;22:1664-71.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C- reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.

Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-26.

Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFa, leptin and IL-6 levels in obese women. Int J Obes. 2004;28:993-7.

Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Dis 2004;2:82-104.

Duman N, Ersoy Evans S, Atakan N. Rosacea and cardiovascular risk factors:a case control study. J Eur Acad Dermatol Venereol 2014;28:1165-9.

Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41:1386-91.

Hayes J, Khandaker G, Anderson J, Mackay D, Zammit S, Lewis G, et al. Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal Med. Psychol Med. 2017;47:23-33.

Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41:1386-91.

Chawes B, Stokholm J, Malby-Schoos A, Fink NR, Brix S, Bisgaard H. Allergic sensitization at school age is a systemic lowgrade Inflammatory disorder. Allergy. 2017;72:1073-80.

Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones P. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life:a population-based longitudinal study. JAMA Psychiatr. 2014;71:1121-8.

Black S, Kushner I, Samols D. C-reactive protein. J Biological Chem. 2004;279(47):48487-90.